110 results
Page 5 of 6
6-K
EX-99
jun46egwzez
5 Jun 13
Extraordinary General Meeting of Shareholders
12:00am
424B5
7noga8nx7jt8y
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
ojdtweb
17 May 13
Prospectus supplement for primary offering
12:00am
6-K
EX-10.1
6hmcfr01mkmv139
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
dado jwzykv
15 Oct 12
Prospectus supplement
12:00am
F-1
q9cgy
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
0d8e4t1rzwjiyjtad5
27 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
9nqbimw gnox3b3s1
10 Sep 12
BioLineRx Announces Pre-clinical Results Demonstrating
12:00am
424B3
z6373djayofr95pa
2 Aug 12
Prospectus supplement
12:00am
POS AM
9ejacgt0m1a 5f9g
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
1yyfh5oa ylaunoza83y
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
424B3
gj9n uiwjl
28 Mar 12
Prospectus supplement
12:00am
20-F
9j39umfeg
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99.2
ib7 i0rsc21w2
16 Feb 12
Current Report, Foreign Issuer
12:00am
6-K
EX-99.3
gz5rl80l
16 Feb 12
Current Report, Foreign Issuer
12:00am
6-K
EX-1
moge82yj8tr tf0ft
6 Sep 11
Orally-Available Molecule for the Treatment of
12:00am
20FR12B/A
wl2a67 i838suash0co
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
EX-4.21
x2gm75r d3b8vf8ds
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.29
8o25anlwjf3rhil8
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am